施贵宝抗Mtbr-Tau靶向抗体BMS-986446获美国FDA快速通道认定,用于阿尔茨海默病治疗

美股速递
Oct 01

施贵宝的抗Mtbr-Tau靶向抗体BMS-986446已获得美国食品药品监督管理局(FDA)快速通道认定,用于阿尔茨海默病的治疗。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10